| [1] |
SHI Shaoxin, CHEN Xueting, XU Xiaofeng, LU Renquan, GUO Lin, ZHUANG Yihui.
Role of coagulation function in bacterial bloodstream infection among malignant tumor patients
[J]. Laboratory Medicine, 2025, 40(8): 804-809.
|
| [2] |
YAN Hua, GAO Dahan, LIU Dongfeng.
Correlation and clinical significance of serum lncRNA THRIL and miR-495-3p expressions with common intestinal bacterial species in children with inflammatory bowel disease
[J]. Laboratory Medicine, 2025, 40(6): 565-570.
|
| [3] |
MA Xiaolu, GUO Lin, LU Renquan.
Clinical value and application prospect of circulating biomarkers in hepatocellular carcinoma patients
[J]. Laboratory Medicine, 2025, 40(4): 309-316.
|
| [4] |
ZHU Jing, ZHANG Rulin, WU Jun.
Expressions of CCNB1，PTTG1 and CBX3 in hepatocellular carcinoma and their roles in prognostic assessment
[J]. Laboratory Medicine, 2025, 40(4): 331-337.
|
| [5] |
YU Jiajie, ZHANG Zhizhi, LUO Qingqiong, KE Xing.
Predicting early colorectal tumor risk using a deep learning model based on multiple serum tumor markers
[J]. Laboratory Medicine, 2025, 40(3): 253-258.
|
| [6] |
YU Xue, QI Aihong, LI Jinhui, QUAN Zhihui, LI Kui, QIU Yurong.
Application role of an AI-patient based real time quality control intelligent monitoring platform for risk quality management of serum tumor markers
[J]. Laboratory Medicine, 2025, 40(3): 264-270.
|
| [7] |
ZHEN Di, JIA Bin, MENG Xianyi.
Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment
[J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
|
| [8] |
BAO Wen.
Application and prospect of microsatellite instability determination in tumor diagnosis and treatment
[J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
|
| [9] |
CHEN Zhijin, WANG Yuting, ZHENG Haiyin, LIU Qingzhong.
Preliminary establishment of the reference range for cytokeratin 19 fragment and analysis of related factors
[J]. Laboratory Medicine, 2025, 40(11): 1070-1074.
|
| [10] |
QI Xinglun, YAO Yifan, SHEN Shushi, YANG Zheng, ZHU Junjie, FAN Lina, YANG Dagan.
Performance evaluation of different large language models in interpreting tumor marker determination reports
[J]. Laboratory Medicine, 2025, 40(11): 1075-1081.
|
| [11] |
LU Xiuming, CHAI Baoying, CAO Yingqi, LIU Xin, YANG Lin.
Roles of serum CA125，TRAP1 and HO-1 in efficacy evaluation of targeted therapy combined with chemotherapy for patients with advanced non-small cell lung cancer
[J]. Laboratory Medicine, 2025, 40(10): 972-977.
|
| [12] |
XU Fei, CHEN Zhujun, YU Liang, ZHANG Jing, LU Renquan, GUO Lin, ZHUANG Yihui.
Analysis of etiological characteristics and death risk factors of candidemia in tumor patients
[J]. Laboratory Medicine, 2024, 39(9): 888-894.
|
| [13] |
LÜ Minmin, HUANG Ying, YU Lan, CAO Liting, ZENG Cuimin.
Determinations of serum interferon regulatory factor 4 and soluble suppression of tumorigenicity 2 in patients with oral periimplantitis
[J]. Laboratory Medicine, 2024, 39(8): 723-727.
|
| [14] |
ZHANG Jialing, QI Jun.
Interference and correction of chylemia on blood cell analysis parameters in tumor patients
[J]. Laboratory Medicine, 2024, 39(8): 770-773.
|
| [15] |
WANG Xuexing, CHEN Chunmei, HE Yuan, CHU Jie, WEI Chunmei.
Roles of thromboelastography and coagulation index in predicting venous thromboembolism in patients with tumors
[J]. Laboratory Medicine, 2024, 39(5): 491-496.
|
